Abstract:BACKGROUND Serotonin receptor 2B (5-HT2B receptor) plays a critical role in many chronic pain conditions. The possible involvement of the 5-HT2B receptor in the altered gut sensation of irritable bowel syndrome with diarrhea (IBS-D) was investigated in the present study. AIM To investigate the possible involvement of 5-HT2B receptor in the altered gut sensation in rat model and patients with IBS-D. METHODS Rectosigmoid biopsies were collected from 18 patients with IBS-D and 10 patients with irritable bowel syndrome with constipation who fulfilled the Rome IV criteria and 15 healthy controls. The expression level of the 5-HT2B receptor in colon tissue was measured using an enzyme-linked immunosorbent assay and correlated with abdominal pain scores. The IBS-D rat model was induced by intracolonic instillation of acetic acid and wrap restraint. Alterations in visceral sensitivity and 5-HT2B receptor and transient receptor potential vanilloid type 1 (TRPV1) expression were examined following 5-HT2B receptor antagonist administration. Changes in visceral sensitivity after administration of the TRPV1 antagonist were recorded. RESULTS Here, we observed greater expression of the 5-HT2B receptor in the colonic mucosa of patients with IBS-D than in that of controls, which was correlated with abdominal pain scores. Intracolonic instillation of acetic acid and wrap restraint induced obvious chronic visceral hypersensitivity and increased fecal weight and fecal water content. Exogenous 5-HT2B receptor agonist administration increased visceral hypersensitivity, which was alleviated by successive administration of a TRPV1 antagonist. IBS-D rats receiving the 5-HT2B receptor antagonist exhibited inhibited visceral hyperalgesia. Moreover, the percentage of 5-HT2B receptor-immunoreactive (IR) cells surrounded by TRPV1-positive cells (5-HT2B receptor I+) and total 5-HT2B receptor IR cells (5-HT2B receptor IT) in IBS-D rats was significantly reduced by the administration of a 5-HT2B receptor antagonist. CONCLUSION Our finding that increased expression of the 5-HT2B receptor contributes to visceral hyperalgesia by inducing TRPV1 expression in IBS-D patients provides important insights into the potential mechanisms underlying IBS-D-associated visceral hyperalgesia.

Effect of Tegaserod on the Serotonin Content in Rat Ileocaecal Mucosa under Partial Restraint Stress

Effects of tegaserod on visceral sensitivity and expression of SP and CGRP in the rat colon

Tegaserod Inhibits Noxious Rectal Distention Induced Responses and Limbic System C-Fos Expression in Rats with Visceral Hypersensitivity

Effects of tegaserod on spinal c-Fos expression in rats with visceral hypersensitivity after rectal distention

Effect of the 5-HT4 Receptor and Serotonin Transporter on Visceral Hypersensitivity in Rats

Tegaserod inhibits noxious rectal distention induced response and spinal nNOS expression in rats with visceral hypersensitivity

Effects of Tegaserod on Fos, Substance P and Calcitonin Gene-Related Peptide Expression Induced by Colon Inflammation in Lumbarsacral Spinal Cord

Study on Changes of Colorectal Serotonin Transporter in Rats with Visceral Hypersensitivity and Treatment with Traditional Chinese Medicine Changji'an

Changes of sensation pressure thresholds before and after treatment with Tegaserod in visceral hypersensitivity rats

Mucosal Serotonin Reuptake Transporter Expression in Irritable Bowel Syndrome Is Modulated by Gut Microbiota Via Mast Cell-Prostaglandin E2

Effect of Changji'an on Visceral Hypersensitivity in Rats with Irritable Bowel Syndrome and Its Mechanism

Changes of spinal evoked potentials and cerebral evoked potentials in visceral hypersensitivity rats before and after Tegaserod treatment

[The Expression of Mucosal IL-1β, TNFα and Serotonin Transporter in Chronic Visceral Hypersensitivity Rats].

Effect of Lactobacillus Rhamnosus GG Supernatant on Serotonin Transporter Expression in Rats with Post-Infectious Irritable Bowel Syndrome.

Antinociceptive Property of Tegaserod in a Rat Model of Chronic Visceral Hypersensitivity.

Epidermal Growth Factor Upregulates Serotonin Transporter and Its Association with Visceral Hypersensitivity in Irritable Bowel Syndrome.

Effect of Acute Restraint Stress on Colonic Sensitivity in Rat

The expression and effect of 5-hydroxytryptamine 7 receptor in brain and intestine of rats with irritable bowel syndrome

Serotonin receptor 2B induces visceral hyperalgesia in rat model and patients with diarrhea-predominant irritable bowel syndrome

Study on Effect of Probiotic Agents on Visceral Sensitivity in Rat Model with Visceral Hypersensitivity

Effects of Acute and Chronic Restraint Stress on Visceral Sensitivity and Neuroendocrine Hormones in Rats